Pacira BioSciences' Assets Average fell 10.53% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 10.53%. This contributed to the annual value of $1.6 billion for FY2024, which is 3.92% down from last year.
Latest data reveals that Pacira BioSciences reported Assets Average of $1.4 billion as of Q3 2025, which was down 9.25% from $1.6 billion recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Assets Average ranged from a high of $2.0 billion in Q1 2022 and a low of $1.3 billion during Q1 2021.
In the last 3 years, Pacira BioSciences' Assets Average had a median value of $1.6 billion in 2025 and averaged $1.6 billion.
As far as peak fluctuations go, Pacira BioSciences' Assets Average surged by 55.05% in 2021, and later dropped by 19.21% in 2023.
Over the past 5 years, Pacira BioSciences' Assets Average (Quarterly) stood at $1.7 billion in 2021, then dropped by 0.46% to $1.7 billion in 2022, then declined by 8.98% to $1.6 billion in 2023, then dropped by 1.08% to $1.5 billion in 2024, then declined by 10.53% to $1.4 billion in 2025.
Its Assets Average was $1.4 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.6 billion in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value